Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Medical Microbiology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1099/jmm.0.027235-0PMID 21127158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.

  2010cited by this paper
• Staphylococcus aureus: a continuously evolving and formidable pathogen in the neonatal intensive care unit.

  2010cited by this paper
• Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland

  2009cited by this paper
• Pre-clinical experience with daptomycin.

  2008cited by this paper
• Single-Dose Pharmacokinetics of Daptomycin in Children With Suspected or Proved Gram-Positive Infections

  2008cited by this paper
• An HPLC assay for daptomycin in serum.

  2008cited by this paper
• Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

  2008cited by this paper
• Daptomycin use in infants: report of two cases with peak and trough drug concentrations

  2008cited by this paper
• Vancomycin In Vitro Bactericidal Activity and Its Relationship to Efficacy in Clearance of Methicillin-Resistant Staphylococcus aureus Bacteremia

  2007cited by this paper
• Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections

  2007cited by this paper
• Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects

  2003cited by this paper

• A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting system

  2025cites this paper
• Daptomycin Experience in the Pediatric and Neonatal Population: A Systematic Review.

  2025cites this paper
• Daptomycin Use for Persistent Coagulase-Negative Staphylococcal Bacteremia in a Neonatal Intensive Care Unit

  2024cites this paper
• Therapeutic Options and Outcomes for the Treatment of Children with Gram-Positive Bacteria with Resistances of Concern: A Systematic Review

  2023cites this paper
• Daptomycin for Treatment of S. Epidermidis Endocarditis in an Extremely Preterm Neonate—Outcome and Perspectives

  2022cites this paper
• Successful daptomycin therapy for a premature neonate with left-sided infective endocarditis caused by Staphylococcus epidermidis.

  2021cites this paper
• The Use of Daptomycin in the Treatment of Persistent Coagulase-Negative Staphylococcal Sepsis in Premature Infants: A Case Series.

  2021cites this paper
• Methicillin-Resistant Staphylococcus aureus Endovascular Infection in a Neonate: Prolonged, Safe, and Effective Use of Daptomycin and Enoxaparin.

  2020cites this paper
• Successful treatment of Staphylococcus haemolyticus endocarditis in extremely premature baby with daptomycin

  2018cites this paper
• Successful Use of High-dose Daptomycin in a Child With Staphylococcus aureus Endocarditis.

  2016cites this paper
• Clinical Effectiveness, Safety Profile, and Pharmacokinetics of Daptomycin in Pediatric Patients: A Systematic Review.

  2016cites this paper
• Daptomycin in paediatrics: current knowledge and the need for future research.

  2015cites this paper
• Access Neonatal Sepsis : An Update

  2015cites this paper
• Daptomycin Use in United States Children's Hospitals.

  2015cites this paper
• Neonatal Sepsis: An Update

  2014cites this paper
• Volume 19 Number 4 April 2013 Daptomycin Use in Infants and Children with Gram-Positive Infections

  2013cites this paper
• A Current Perspective on Daptomycin for the Clinical Microbiologist

  2013cites this paper
• Species Distribution and Susceptibilities of Bacteraemic Isolates from a United Kingdom Level 3 Neonatal Intensive Care Unit, a 5 Year Experience

  2013cites this paper
• Daptomycin Use in Infants and Children with Gram-Positive Infections

  2013cites this paper
• Use of daptomycin in neonates: A case report and review of the literature

  2012cites this paper
• Daptomycin: a review of properties, clinical use, drug delivery and resistance.

  2012cites this paper
• Future Directions in the Evaluation and Management of Neonatal Sepsis

  2012cites this paper
• Current world literature.

  2011cites this paper